Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/0-387-32824-6_19PMID 16700521
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD4 T cell activation and disease activity at onset of multiple sclerosis.

  2004cited by this paper
• A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-β-naphthylamide

  2004cited by this paper
• Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites.

  2003cited by this paper
• Synergistic action of DPIV and APN in the regulation of T cell function.

  2003cited by this paper
• Dipeptidyl peptidase IV substrates. An update on in vitro peptide hydrolysis by human DPPIV.

  2003cited by this paper
• Anergic T cells exert antigen-independent inhibition of cell-cell interactions via chemokine metabolism.

  2003cited by this paper
• Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.

  2003cited by this paper
• Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV

  2003cited by this paper
• Targeting Dipeptidyl Peptidase IV (CD26) Suppresses Autoimmune Encephalomyelitis and Up-Regulates TGF-β1 Secretion In Vivo1

  2001cited by this paper
• Kinetic Investigation of Chemokine Truncation by CD26/Dipeptidyl Peptidase IV Reveals a Striking Selectivity within the Chemokine Family*

  2001cited by this paper
• Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities?

  2001cited by this paper
• CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO

  2001cited by this paper
• Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.

  2001cited by this paper
• Dipeptidyl Peptidase IV (DP IV/CD26) mRNA Expression in PWM-Stimulated T-Cells Is Suppressed by Specific DP IV Inhibition, an Effect Mediated by TGF-β1

  2000cited by this paper
• Touching base

  2000cited by this paper
• Dipeptidyl peptidase IV (DP IV/CD26) mRNA expression in PWM-stimulated T-cells is suppressed by specific DP IV inhibition, an effect mediated by TGF-beta(1).

  2000cited by this paper
• Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis.

  2000cited by this paper
• Effects of nonapeptides derived from the N-terminal structure of human immunodeficiency virus-1 (HIV-1) Tat on suppression of CD26-dependent T cell growth.

  2000cited by this paper
• Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses.

  2000cited by this paper
• CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis.

  2000cited by this paper
• Dipeptidyl peptidase IV in inflammatory CNS disease.

  2000cited by this paper
• Amino‐terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV)

  2000cited by this paper
• Down-regulation of T Cell Activation following Inhibition of Dipeptidyl Peptidase IV/CD26 by the N-terminal Part of the Thromboxane A2 Receptor*

  2000cited by this paper
• HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis.

  2000cited by this paper
• CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis

  2000cited by this paper
• CD26, let it cut or cut it down.

  1999cited by this paper
• CD26/DPP IV-mediated modulation of acute rejection.

  1999cited by this paper
• CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response.

  1999cited by this paper
• Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review).

  1999cited by this paper
• Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones.

  1998cited by this paper
• Anti-arthritic effects of the novel dipeptidyl peptidase IV inhibitors TMC-2A and TSL-225.

  1998cited by this paper
• The effects of CD26/DPP IV-targeted therapy on acute allograft rejection.

  1997cited by this paper
• Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) induces secretion of transforming growth factor-beta 1 (TGF-beta 1) in stimulated mouse splenocytes and thymocytes.

  1997cited by this paper
• CD26/dipeptidyl peptidase IV in lymphocyte growth regulation.

  1997cited by this paper
• Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV

  1997cited by this paper
• Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) induces secretion of transforming growth factor-β1 (TGF-β1) in stimulated mouse splenocytes and thymocytes

  1997cited by this paper
• Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV.

  1997cited by this paper
• Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor‐β1 in PWM‐stimulated PBMC and T cells

  1997cited by this paper
• The N-terminal Structure of HIV-1 Tat Is Required for Suppression of CD26-dependent T Cell Growth*

  1997cited by this paper
• Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients.

  1997cited by this paper
• The N‐terminal X‐X‐Pro sequence of the HIV‐1 Tat protein is important for the inhibition of dipeptidyl peptidase IV (DP IV/CD26) and the suppression of mitogen‐induced proliferation of human T cells

  1996cited by this paper
• Transforming growth factor beta 1 inhibits interleukin-10 mRNA expression and production in pokeweed mitogen-stimulated peripheral blood mononuclear cells and T cells.

  1995cited by this paper
• Transforming Growth Factor β1 Inhibits Interleukin-10 mRNA Expression and Production in Pokeweed Mitogen-Stimulated Peripheral Blood Mononuclear Cells and T Cells

  1995cited by this paper
• Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation.

  1995cited by this paper
• A longitudinal study of the T cell activation marker CD26 in chronic progressive multiple sclerosis.

  1995cited by this paper
• Transforming growth factor-beta 1 (TGF-beta 1) inhibits DNA synthesis of PWM-stimulated PBMC via suppression of IL-2 and IL-6 production.

  1994cited by this paper
• Transforming growth factor-β1 (TGF-β1) inhibits DNA synthesis of PWM-stimulated PBMC via suppression of IL-2 and IL-6 production

  1994cited by this paper
• CD26: a surface protease involved in T-cell activation.

  1994cited by this paper
• Direct association of adenosine deaminase with a T cell activation antigen, CD26.

  1993cited by this paper
• Evidence that thymocyte-activating molecule is mouse CD26 (dipeptidyl peptidase IV).

  1991cited by this paper
• Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.

  1991cited by this paper
• Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.

  1990cited by this paper
• The dipeptidyl peptidase IV, a membrane enzyme involved in the proliferation of T lymphocytes.

  1985cited by this paper
• In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.

  1985cited by this paper
• Involvement of plasma membrane dipeptidyl peptidase IV in fibronectin-mediated adhesion of cells on collagen.

  1985cited by this paper
• Studies on glycyl-proline naphthylamidase

  1977cited by this paper
• A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide.

  1966cited by this paper

• Molecular Characterization and Biological Function of a Novel LncRNA CRNG in Swine

  2019cites this paper
• CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression.

  2016cites this paper
• NPY suppressed development of experimental autoimmune encephalomyelitis in Dark Agouti rats by disrupting costimulatory molecule interactions.

  2012cites this paper
• Inhibition of DPP IV is a suggested mechanism of the immunomodulatory effects of sparfloxacin

  2012influential citation
• PETIR-001, a dual inhibitor of dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN), ameliorates experimental autoimmune encephalomyelitis in SJL/J mice

  2011cites this paper
• Neuroendocrine regulatory role of Merkel cells in the pathogenesis of psoriasis

  2011cites this paper
• Divergent actions by inhibitors of DP IV and APN family enzymes on CD4+ Teff cell motility and functions.

  2011cites this paper
• Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice

  2009cites this paper
• Receptor US 28 Cytomegalovirus-Encoded Chemokine Receptors CCR 1 and CCR 5 and the Human CCL 14 a to Activity on the Chemokine Significance of N-Terminal Proteolysis of

  2009cites this paper
• Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors.

  2008cites this paper
• Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation.

  2007cites this paper